Literature DB >> 15231587

Benefits and harms of drug treatments.

Jan P Vandenbroucke.   

Abstract

Mesh：

Year:  2004        PMID： 15231587      PMCID： PMC443425          DOI： 10.1136/bmj.329.7456.2

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  10 in total

Review 1.  Assessing the quality of research.

Authors:  Paul Glasziou; Jan P Vandenbroucke; Iain Chalmers
Journal:  BMJ       Date:  2004-01-03

2.  Balancing benefits and harms in health care.

Authors:  Luis Gabriel Cuervo; Mike Clarke
Journal:  BMJ       Date:  2003-07-12

3.  When are observational studies as credible as randomised trials?

Authors:  Jan P Vandenbroucke
Journal:  Lancet       Date:  2004-05-22       Impact factor: 79.321

Review 4.  Synthesising licensing data to assess drug safety.

Authors:  Klim McPherson; Elina Hemminki
Journal:  BMJ       Date:  2004-02-28

Review 5.  Observational research and evidence-based medicine: What should we teach young physicians?

Authors:  J P Vandenbroucke
Journal:  J Clin Epidemiol       Date:  1998-06       Impact factor: 6.437

6.  Choosing the best research design for each question.

Authors:  D L Sackett; J E Wennberg
Journal:  BMJ       Date:  1997 Dec 20-27

7.  The case for recording events in clinical trials.

Authors:  D C Skegg; R Doll
Journal:  Br Med J       Date:  1977-12-10

8.  The discovery of drug-induced illness.

Authors:  H Jick
Journal:  N Engl J Med       Date:  1977-03-03       Impact factor: 91.245

9.  A comparison of three different sources of data in assessing the frequencies of adverse reactions to amiodarone.

Authors:  Yoon K Loke; Sheena Derry; Jeffrey K Aronson
Journal:  Br J Clin Pharmacol       Date:  2004-05       Impact factor: 4.335

10.  Reporting of adverse drug reactions in randomised controlled trials - a systematic survey.

Authors:  Y K Loke; S Derry
Journal:  BMC Clin Pharmacol       Date:  2001-09-12
  10 in total
  10 in total

1.  Assessing the benefit-harm balance at the bedside.

Authors:  Yoon Kong Loke
Journal:  BMJ       Date:  2004-07-03

2.  Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis.

Authors:  Julia Hippisley-Cox; Carol Coupland
Journal:  BMJ       Date:  2005-06-11

3.  Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies.

Authors:  Panagiotis N Papanikolaou; Georgia D Christidi; John P A Ioannidis
Journal:  CMAJ       Date:  2006-02-28       Impact factor: 8.262

Review 4.  Risks and benefits of (pharmaco)epidemiology.

Authors:  Lesley Wise
Journal:  Ther Adv Drug Saf       Date:  2011-06

5.  Baseline albuminuria predicts the efficacy of blood pressure-lowering drugs in preventing cardiovascular events.

Authors:  Cornelis Boersma; Maarten J Postma; Sipke T Visser; Jarir Atthobari; Paul E de Jong; Lolkje T W de Jong-van den Berg; Ron T Gansevoort
Journal:  Br J Clin Pharmacol       Date:  2008-01-30       Impact factor: 4.335

Review 6.  Adverse Events of Mind-Body Interventions in Children: A Systematic Review.

Authors:  Meagan Lyszczyk; Mohammad Karkhaneh; Kerri Kaiser Gladwin; Martha Funabashi; Liliane Zorzela; Sunita Vohra
Journal:  Children (Basel)       Date:  2021-04-29

Review 7.  Meta-analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: methodological overview.

Authors:  Su Golder; Yoon K Loke; Martin Bland
Journal:  PLoS Med       Date:  2011-05-03       Impact factor: 11.069

Review 8.  The association between systemic glucocorticoid therapy and the risk of infection in patients with rheumatoid arthritis: systematic review and meta-analyses.

Authors:  William G Dixon; Samy Suissa; Marie Hudson
Journal:  Arthritis Res Ther       Date:  2011-08-31       Impact factor: 5.156

9.  Efficacy and safety of rapid tests to guide antibiotic prescriptions for sore throat.

Authors:  Jérémie F Cohen; Jean-Yves Pauchard; Nils Hjelm; Robert Cohen; Martin Chalumeau
Journal:  Cochrane Database Syst Rev       Date:  2020-06-04

10.  Evaluating harm associated with anti-malarial drugs: a survey of methods used by clinical researchers to elicit, assess and record participant-reported adverse events and related data.

Authors:  Elizabeth N Allen; Clare I R Chandler; Nyaradzo Mandimika; Cheryl Pace; Ushma Mehta; Karen I Barnes
Journal:  Malar J       Date:  2013-09-16       Impact factor: 2.979
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.